Reset filter
Keywords
Kidney Neoplasms ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

45 Search results.

Relevance Rating New first Old first

Eligibility Renal Cell Carcinoma NCT00610389

- 9/20/21 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria,Exclusion Criteria
Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors; ODM derived from: https://clinicaltrials.gov/show/NCT00610389

Kidney Cancer NCT01198158 Registration - CALGB 90802 Registration Worksheet Form - 3103555v1.0 - CALGB 90802 Registration Worksheet Form

- 9/20/21 - 1 form, 10 itemgroups, 44 items, 1 language
Itemgroups: Header Module,Protocol Administration,Patient Demographics/Pre-Treatment Characteristics1,Patient Demographics/Pre-Treatment Characteristics2,Patient Demographics/Pre-Treatment Characteristics3,Certification Of Eligibility,Protocol Design,Initial Patient Consent For Specimen Use,CALGB 580902,Registration Information
CALGB 90802 Registration Worksheet Form Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=879626AD-DB8C-4AF2-E040-BB89AD4364E1

E2805 Renal Cell Carcinoma On-Study Form NCT00326898

- 9/20/21 - 1 form, 9 itemgroups, 50 items, 1 language
Itemgroups: Header,Data amendment,Patient demographics,History of Disease,Description of Primary Disease,Description of Current Disease,Current Disease Symptoms,MUGA Scanning,Footer Module
E2805 Renal Cell Carcinoma On-Study Form NCT00326898 Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=053ADDEA-1681-66BC-E044-0003BA3F9857

E2805 Material Submission Form NCT00326898

- 9/20/21 - 1 form, 6 itemgroups, 31 items, 1 language
Itemgroups: Header,Patient demographics,Biopsy specimen / Lab,Completed by Central Lab,Contacts,Comments
E2805 Material Submission Form NCT00326898 Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=05B6F9C4-7323-1449-E044-0003BA3F9857

E2805 Follow-up Disease Evaluation Form NCT00326898

- 9/20/21 - 1 form, 6 itemgroups, 30 items, 1 language
Itemgroups: ECOG clinical trial administrative data,Data amendment,Cycle number,Section I - Clinical Assessment,Section II - Notice of Recurrence,Footer module
E2805 Follow-up Disease Evaluation Form NCT00326898 Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=054D0EB8-8174-3DEA-E044-0003BA3F9857

Kidney Cancer NCT00357760 Eligibility - E4805 Registration Worsksheet - Step 1 - 3056754v1.0 - E4805 Registration Worsksheet - Step 1

- 9/20/21 - 1 form, 3 itemgroups, 26 items, 1 language
Itemgroups: Eligibility,Demographic Data Required For Patient Registration,I have reviewed the above data and agree the date are accurate and correct
E4805 Registration Worsksheet - Step 1 VEGF Trap in Treating Patients With Metastatic or Unresectable Kidney Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=83D1F61D-EFC6-FE74-E040-BB89AD436539

Kidney Cancer NCT01120249 Response - Southwest Oncology Group S0931 Recurrence Assessment Form (Form #46940) - 2998562v1.0 - Southwest Oncology Group S0931 Recurrence Assessment Form (Form #46940)

- 9/20/21 - 1 form, 4 itemgroups, 24 items, 1 language
Itemgroups: Header Module,Clinical Assessment,Notice of Recurrence,COMMENTS
Southwest Oncology Group S0931 Recurrence Assessment Form (Form #46940) Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7E26385C-8CD8-C34F-E040-BB89AD434A8D

Kidney Cancer NCT01164228 Eligibility - E1808 Registration Worksheet (step 1) - 3084118v1.0 - E1808 Registration Worksheet (step 1)

- 9/17/21 - 1 form, 3 itemgroups, 24 items, 1 language
Itemgroups: Eligibility,Demographic Data Required For Patient Registration,I have reviewed the above data and agree the date are accurate and correct
E1808 Registration Worksheet (step 1) Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=863E7AF9-E486-FB2D-E040-BB89AD43214E

Kidney Cancer NCT00378703 Eligibility - E2804 Registration Worsksheet - 2680170v1.0 - E2804 Registration Worsksheet

- 9/17/21 - 1 form, 3 itemgroups, 27 items, 1 language
Itemgroups: Eligibility,Demographic Data Required For Patient Registration,I have reviewed the above data and agree the date are accurate and correct
E2804 Registration Worsksheet Bevacizumab, Sorafenib, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=39DE83BC-8CC5-21F3-E044-0003BA3F9857

Kidney Cancer NCT00326898 Eligibility - E2805 Registration Worksheet (step 2) - 2766277v1.0 - E2805 Registration Worksheet (step 2)

- 9/17/21 - 1 form, 2 itemgroups, 29 items, 1 language
Itemgroups: Eligibility,Patient Demographics / Pre-Treatment Characteristics
E2805 Registration Worksheet (step 2) Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=51FE4236-C92E-577B-E044-0003BA3F9857

Kidney Cancer NCT00326898 Eligibility - E2805 Registration Worksheet (step 1) - 2766140v1.0 - E2805 Registration Worksheet (step 1)

- 9/17/21 - 1 form, 2 itemgroups, 33 items, 1 language
Itemgroups: Eligibility,Patient Demographics / Pre-Treatment Characteristics
E2805 Registration Worksheet (step 1) Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=51FCB83B-9355-3F89-E044-0003BA3F9857

Eligibility Collecting Duct Carcinoma (Kidney) NCT02363751

- 3/1/19 - 1 form, 2 itemgroups, 42 items, 1 language
Itemgroups: Inclusion Criteria,Exclusion Criteria
Study of Gemcitabine+Platinium Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (BEVABEL); ODM derived from: https://clinicaltrials.gov/show/NCT02363751

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial